Hydrolytically activated etoposide prodrugs inhibit MDR-1 function and eradicate established MDR-1 multidrug-resistant T-cell leukemia.
Schroeder U, Bernt KM, Lange B, Wenkel J, Jikai J, Shabat D, Amir R, Huebener N, Niethammer AG, Hagemeier C, Wiebusch L, Gaedicke G, Wrasidlo W, Reisfeld RA, Lode HN.
Schroeder U, et al. Among authors: hagemeier c.
Blood. 2003 Jul 1;102(1):246-53. doi: 10.1182/blood-2002-07-2268. Epub 2003 Mar 6.
Blood. 2003.
PMID: 12623853
Free article.